Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Convergence Pharmaceuticals Limited patents


Recent patent applications related to Convergence Pharmaceuticals Limited. Convergence Pharmaceuticals Limited is listed as an Agent/Assignee. Note: Convergence Pharmaceuticals Limited may have other listings under different names/spellings. We're not affiliated with Convergence Pharmaceuticals Limited, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Convergence Pharmaceuticals Limited-related inventors


Process for preparing alpha-carboxamide pyrrolidine derivatives

The invention relates to a novel process for preparing α-carboxamide pyrrolidine derivatives, in particular (2s, 5r)-5-(4-((2-fluorobenzyl)oxy)phenyl)pyrrolidine-2-carboxamide, and to novel intermediates for use in said process along with processes for preparing said intermediates.. . ... Convergence Pharmaceuticals Limited

Novel pyrimidinyl-diazospiro compounds

The invention relates to spiro deriviatives, to the use of said derivatives in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation.. . ... Convergence Pharmaceuticals Limited

Paroxysmal extreme pain disorder treatment

The present invention is directed to the treatment of paroxysmal extreme pain disorder (pepd) comprising administering to a subject in need thereof, a therapeutically effective amount of 5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-prolinamide or a pharmaceutically acceptable salt, solvate or prodrug thereof.. . ... Convergence Pharmaceuticals Limited

Novel erythromelalgia treatment

The present invention is directed to the treatment of erythromelalgia comprising administering to a subject in need thereof, a therapeutically effective amount of 5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-prolinamide or a pharmaceutically acceptable salt, solvate or prodrug thereof.. . ... Convergence Pharmaceuticals Limited

Novel small fibre neuropathy treatment

The present invention is directed to the treatment of small fibre neuropathy comprising administering to a subject in need thereof, a therapeutically effective amount of 5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-prolinamide or a pharmaceutically acceptable salt, solvate or prodrug thereof.. . ... Convergence Pharmaceuticals Limited

Diagnostic method

The invention relates to a method of diagnosing a paroxysmal pain disorder, such as trigeminal neuralgia, in a human subject and also provides a method of identifying patients most likely to respond to therapy and to kits for use in said methods.. . ... Convergence Pharmaceuticals Limited








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Convergence Pharmaceuticals Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Convergence Pharmaceuticals Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###